BBA
TGTX icon

Baader Bank Aktiengesellschaft’s TG Therapeutics TGTX Stock Holding History

Baader Bank Aktiengesellschaft’s Portfolio TGTX Stock Details TGTX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$385K Buy
+7,000
New +$286K 0.03% 340
2025
Q2 		– Sell
-12,618
Closed -$492K – 511
2025
Q1 		$492K Buy
+12,618
New +$425K 0.04% 235
2024
Q4 		– Sell
-25,500
Closed -$596K – 496
2024
Q3 		$596K Buy
+25,500
New +$557K 0.03% 226

Other funds holding TGTX

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
D.E. Shaw & Co
D.E. Shaw & Co New York $210B AUM 57.28% 1-Year Est. Return
SCM
Soleus Capital Management Greenwich, Connecticut $2.9B AUM 169.69% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
ClearBridge Investments
ClearBridge Investments New York $121B AUM 27.52% 1-Year Est. Return
CAM
Congress Asset Management Boston, Massachusetts $16.3B AUM 42.69% 1-Year Est. Return

Baader Bank Aktiengesellschaft's TGTX Position: Q2 2026 in Review

Baader Bank Aktiengesellschaft opened a new position in TG Therapeutics (TGTX) in Q2 2026: 7,000 shares worth $385K. The stake represents 0.03% of the portfolio and ranks #340 among its holdings. This is a return to the name: Baader Bank Aktiengesellschaft previously reported a position in TGTX as recently as Q1 2025.

Baader Bank Aktiengesellschaft first reported a position in TGTX in Q3 2024 and has held it in 3 quarters since. The position peaked at $596K in Q3 2024. 429 funds tracked by Wall St. Rank hold TGTX as of Q2 2026.

  • Baader Bank Aktiengesellschaft held 7,000 shares of TG Therapeutics worth $385K as of Q2 2026.
  • TG Therapeutics was a new Baader Bank Aktiengesellschaft position in Q2 2026.
  • TG Therapeutics made up 0.03% of Baader Bank Aktiengesellschaft's portfolio in Q2 2026, its #340 holding.
  • Baader Bank Aktiengesellschaft first reported a position in TG Therapeutics in Q3 2024 and has held it in 3 quarters since.
  • Baader Bank Aktiengesellschaft's TG Therapeutics position peaked at $596K in Q3 2024.
  • 429 funds tracked by Wall St. Rank held TG Therapeutics as of Q2 2026.

Based on Baader Bank Aktiengesellschaft's 13F filing for Q2 2026, filed 23 Jul 2026.